Signaling Pathways - RET - IMPDH - angiogenesis - Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)
清除全部
-
B1112 MerimepodibTarget: IMPDHSummary: IMPDH（肌苷单磷酸脱氢酶）的新型非竞争性抑制剂 -
A2174 Lenvatinib (E7080)中文名: 乐伐替尼，仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂 -
A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂 -
A4506 DMOGTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: 细胞通透的竞争性HIF-PH抑制剂 -
A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂 -
A4211 Lenalidomide (CC-5013)中文名: 来那度胺Target: angiogenesisSummary: 抗肿瘤药物，抑制血管生成。 -
A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂